Techsol’s New Business Outlook With Our New Brand Identity

Home / Press Releases / Techsol’s New Business Outlook With Our New Brand Identity

PRINCETON, N.J. April 07, 2022: We are very happy and proud to annouce that we have successfully completed 12 Years as a Life Sciences solutions provider. This remarkable journey would not have been possible without the trust and continuous support from our esteemed clients, partners and industry leaders.  Along this way, we have reflected on ideologies that shaped our thinking more towards the delivering of excellence through process-oriented technology innovation.

Techsol – 2022 and Beyond

Since March 2010, we have evolved as a company from providing Life Sciences Technology Services to offering innovative SaaS platforms for increasing quality, compliance, and productivity across the clinical, drug safety and medical affairs industry verticals.

Going forward from 2022, we have expanded our business solution offerings with the following focus areas:

  • End-to-End Clinical Research Services – We successfully acquired Hinge Clinica, a global CRO which is highly specialized in offering full-range Clinical Research services for global Biopharmaceutical, Medical Device, Food and Nutraceutical companies.
  • Quality Technology Consulting – Through our partnership with Sparta Systems, a Honeywell Company, Techsol offers specialized consulting TrackWise QMS and other Digital Quality Tech services.
  • Compier GxP Ops and Oversight Platform – We have launched our automation-driven Compier SaaS platform to digitalize PV business functions such as Aggregate Reporting, SDEA Management, Literature Screening, and ePSMF.
  • Validation and Compliance Assurance – With a unique service model, Techsol’s Validation-as-a-Service (VaaS) focuses on enabling sponsors to establish a robust validation lifecycle management across GxP applications using our e-validation platform and SMEs.
  • Clinical and Regulatory Technology – To address the business need of IDMP, xEVMPD, EU-MDR and UDI Compliance, we are providing regulatory consulting services. Another key offering that we have introduced is the CDISC data transformation services.
  • Medical Affairs Programs and Collaboration Portals – Our subsidiary, SciMax Global, a fully integrated SaaS platform for medical affairs is now offering digital capabilities for scientific publications management, IITs, Grants, EAP and enhanced collaboration portals.

With our current business portfolio expansion, we are now an end-to-end Life Sciences solutions and services platform company with a strong focus on clinical development, medical affairs and post-marketing surveillance. To commemorate this historical milestone and to unfold our new outlook and aspirations, we are thrilled to let you know that we will henceforth be known as “Techsol Life Sciences” in the industry.

“We have refreshed our brand identity with a new logo and tagline to denote the unwavering focus we have towards our mission of helping pharma to bring new medcinal products to the market. We want to be a trusted partner that offers end-to-end Life Sciences technology and scientific process solutions for our clients”, says Satya S S Sagi, CEO & Founder of Techsol Life Sciences.

About Our New Look

Techsol Life Sciences

Since March 2010, we have evolved as a company from providing Life Sciences Technology Services to offering innovative SaaS platforms for increasing quality, compliance, and productivity across the clinical, drug safety and medical affairs industry verticals.

Our new logo reflects our aspirations of helping sponsors to “NAVIGATE TO EXCELLENCE” across the pharma value-chain with our powerful combination of scientific process knowledge and cutting-edge technology solutions.

In this spirit of rebranding, our determination towards your success is fueled even more with our core values, competence, and through our people. We are looking forward to strengthening our collaboration while starting this new growth chapter.

What’s Next

We will continue to send timely communication through appropriate channels on progressive updates across our business platforms, website, and social media that addresses legal, statutory and other corporate related changes.

As you notice these changes in our branding, and promotions, we would certainly love to connect with you to introduce our new capabilities. Please feel free to reach out with any thoughts, requests, or compliments. If you enjoy social media, please follow our news and updates through our website and LinkedIn page.

About Techsol Life Sciences

Techsol Life Sciences is an integrated clinical development, medical affairs and post-marketing surveillance business solutions provider to global biopharmaceutical, medical device, food, and nutraceuticals companies. With our commitment to bringing novel treatments and therapies faster to market, we deliver regulatory compliant clinical research services, GxP technology consulting solutions in combination with our unified SaaS platforms.

Using our deep-domain scientific expertise and technology innovation, we help sponsors to reduce time-to-market, save costs, and realize maximum value, across pharmaceutical and medical device business functions through insights-driven clinical research, compliance oversight, digitalization and GxP process automation.